News
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
1don MSN
There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to ...
Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...
Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
4d
24/7 Wall St. on MSNPfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy?Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...
We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...
There are worse fates than being a household name, declaring generous quarterly distributions, and being currently out of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results